NCT03493152No Longer Available不适用
Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
研究概览
简要总结
Single patient treatment with everolimus.
研究设计
- 研究类型
- Expanded Access
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
No Longer Available
不适用
Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)Uterine SarcomaNCT03493165The University of Texas Health Science Center at San Antonio
Unknown
2 期
Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety StudyMelanomaTOR Serine-Threonine KinasesNeoplasm MetastasisNCT01960829Peking University Cancer Hospital & Institute60
终止
2 期
Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine TumorsGastrointestinal TumorsPancreatic TumorsGastrointestinal Neuroendocrine TumorsPancreatic Neuroendocrine TumorsNCT01648465Hellenic Cooperative Oncology Group25
No Longer Available
不适用
Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple MyelomaMultiple MyelomaNCT02541643Sundar Jagannath
已完成
2 期
Everolimus for Patients With Relapsed/Refractory Germ Cell CancerGerm Cell CancerTesticular CancerNCT01242631Hannover Medical School25